Surgical site infection after laparoscopic resection of colorectal cancer is associated with compromised long-term oncological outcome.


Journal

World journal of surgical oncology
ISSN: 1477-7819
Titre abrégé: World J Surg Oncol
Pays: England
ID NLM: 101170544

Informations de publication

Date de publication:
07 Apr 2022
Historique:
received: 09 01 2022
accepted: 18 03 2022
entrez: 7 4 2022
pubmed: 8 4 2022
medline: 9 4 2022
Statut: epublish

Résumé

We evaluated the influence of infectious complications, particularly surgical site infection (SSI), on long-term oncological results after elective laparoscopic resection of colorectal cancer. A total of 199 patients who underwent laparoscopic elective resection with negative resection margins for stage I-III colorectal cancer were retrospectively examined. The postoperative course was recorded based on hospital records, and cancer relapse was diagnosed based on radiological or pathological findings under a standardized follow-up program. The severity of complications was graded using Clavien-Dindo (CD) classification. SSI was found in 25 patients (12.6%), with 12 (6.0%) showing anastomotic leak. The postoperative relapse-free survival (RFS) rate was significantly lower in patients with SSI (49.2%) than in patients without SSI (87.2%, P<0.001). Differences in RFS were found after both colectomy and rectal resection (P<0.001 and P<0.001, respectively). RFS did not differ between patients who had major SSI CD (grade III) and those who had minor SSI CD (grades I or II). Multivariate Cox regression analysis identified the occurrence of SSI and pathological stage as independent co-factors for RFS (P<0.001 and P=0.003). These results suggest that postoperative SSI compromises long-term oncological results after laparoscopic colorectal resection. Further improvements in surgical technique and refinements in perioperative care may improve long-term oncological results.

Sections du résumé

BACKGROUND BACKGROUND
We evaluated the influence of infectious complications, particularly surgical site infection (SSI), on long-term oncological results after elective laparoscopic resection of colorectal cancer.
METHODS METHODS
A total of 199 patients who underwent laparoscopic elective resection with negative resection margins for stage I-III colorectal cancer were retrospectively examined. The postoperative course was recorded based on hospital records, and cancer relapse was diagnosed based on radiological or pathological findings under a standardized follow-up program. The severity of complications was graded using Clavien-Dindo (CD) classification.
RESULTS RESULTS
SSI was found in 25 patients (12.6%), with 12 (6.0%) showing anastomotic leak. The postoperative relapse-free survival (RFS) rate was significantly lower in patients with SSI (49.2%) than in patients without SSI (87.2%, P<0.001). Differences in RFS were found after both colectomy and rectal resection (P<0.001 and P<0.001, respectively). RFS did not differ between patients who had major SSI CD (grade III) and those who had minor SSI CD (grades I or II). Multivariate Cox regression analysis identified the occurrence of SSI and pathological stage as independent co-factors for RFS (P<0.001 and P=0.003).
CONCLUSION CONCLUSIONS
These results suggest that postoperative SSI compromises long-term oncological results after laparoscopic colorectal resection. Further improvements in surgical technique and refinements in perioperative care may improve long-term oncological results.

Identifiants

pubmed: 35387666
doi: 10.1186/s12957-022-02578-2
pii: 10.1186/s12957-022-02578-2
pmc: PMC8988355
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

111

Informations de copyright

© 2022. The Author(s).

Références

Int J Colorectal Dis. 2011 Apr;26(4):415-21
pubmed: 21174107
Int J Surg. 2018 Apr;52:303-308
pubmed: 29530829
Br J Cancer. 2011 Feb 15;104(4):726-34
pubmed: 21266974
Cancer Cell. 2009 Feb 3;15(2):103-13
pubmed: 19185845
Dis Colon Rectum. 2013 Jan;56(1):20-8
pubmed: 23222276
Ann Coloproctol. 2020 Aug;36(4):273-280
pubmed: 32054256
J Gastrointest Surg. 2018 Aug;22(8):1418-1433
pubmed: 29589264
Lancet Gastroenterol Hepatol. 2017 Apr;2(4):261-268
pubmed: 28404155
Surg Today. 2017 Jun;47(6):743-754
pubmed: 27783149
Ann Surg. 2014 Jul;260(1):23-30
pubmed: 24509190
BMJ. 2015 Jan 02;350:g7607
pubmed: 25555821
J Biol Chem. 2003 Jun 13;278(24):21631-8
pubmed: 12690099
Gastroenterology. 2015 Sep;149(3):614-22
pubmed: 26026393
Clin Colorectal Cancer. 2017 Dec;16(4):264-274
pubmed: 28412137
BMC Cancer. 2019 Aug 23;19(1):833
pubmed: 31443699
Ann Surg. 2017 Mar;265(3):539-546
pubmed: 27070934
Dis Colon Rectum. 2016 Mar;59(3):236-44
pubmed: 26855399
Chin J Cancer. 2017 Dec 21;36(1):96
pubmed: 29268783
Br J Cancer. 2009 Mar 10;100(5):701-6
pubmed: 19209171
JAMA Surg. 2015 Sep;150(9):890-8
pubmed: 26132363
Ann Surg. 2011 May;253(5):890-9
pubmed: 21394013
J Clin Oncol. 2008 Jan 10;26(2):303-12
pubmed: 18182672
Int J Surg. 2015 Oct;22:3-9
pubmed: 26283295
BMC Cancer. 2017 Nov 10;17(1):744
pubmed: 29126400
Int J Colorectal Dis. 2019 Feb;34(2):319-328
pubmed: 30470941
Ann Surg Oncol. 2009 Feb;16(2):311-8
pubmed: 19037699
J Am Coll Surg. 2010 Aug;211(2):232-8
pubmed: 20670861
Int J Colorectal Dis. 2016 Nov;31(11):1775-1784
pubmed: 27604812
Ann Surg. 2014 May;259(5):930-8
pubmed: 24045445
Ann Surg. 2012 Dec;256(6):1034-8
pubmed: 22584695
Surgery. 2017 Aug;162(2):317-324
pubmed: 28433249
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Int J Colorectal Dis. 2020 Mar;35(3):413-422
pubmed: 31897647
Surg Today. 1998;28(6):576-9
pubmed: 9681604
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Ann Surg. 2006 Nov;244(5):758-63
pubmed: 17060769
Gastroenterology. 2010 Jun;138(6):2101-2114.e5
pubmed: 20420949
Dis Colon Rectum. 2019 Mar;62(3):286-293
pubmed: 30540662
J Anus Rectum Colon. 2019 Oct 30;3(4):175-195
pubmed: 31768468
Br J Cancer. 2007 Nov 5;97(9):1211-7
pubmed: 17968426
Br J Cancer. 2010 Sep 7;103(6):870-6
pubmed: 20717110
Int J Colorectal Dis. 2019 Feb;34(2):277-283
pubmed: 30426197
Oncol Lett. 2010 Jan;1(1):119-125
pubmed: 22966268
Colorectal Dis. 2015 Feb;17(2):141-9
pubmed: 25156234
Am J Surg. 2011 Sep;202(3):259-64
pubmed: 21871980
Ann Surg. 2011 Jul;254(1):83-9
pubmed: 21572320
Medicine (Baltimore). 2016 Apr;95(14):e3271
pubmed: 27057884
Ann Surg Oncol. 2018 Jan;25(1):188-196
pubmed: 29116488
Am J Infect Control. 1999 Apr;27(2):97-132; quiz 133-4; discussion 96
pubmed: 10196487
Ann Surg Oncol. 2013 May;20(5):1575-83
pubmed: 23076557
World J Gastroenterol. 2017 Sep 14;23(34):6212-6219
pubmed: 28974887

Auteurs

Nana Sugamata (N)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Takashi Okuyama (T)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan. okuyama615@gmail.com.

Emiko Takeshita (E)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Haruka Oi (H)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Yuhei Hakozaki (Y)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Shunya Miyazaki (S)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Musashi Takada (M)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Takashi Mitsui (T)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Takuji Noro (T)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Hideyuki Yoshitomi (H)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Masatoshi Oya (M)

Department of Surgery, Dokkyo Medical University Saitama Medical Center, 2-1-50 Minami-Koshigaya, Koshigaya, Saitama, 343-8555, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH